[Psychiatric symptoms related to interferon treatment for chronic XXXX ].

@entity1 @entity162 @entity308 @entity146 @entity1833 @entity1316 @entity148 @entity933 @entity99 @entity3027
Psychiatric symptoms related to interferon ( @entity3027 ) treatment for chronic @entity99 have been a crucial issue in consultation liaison psychiatry. In this report we present a hypothesis regarding the development of @entity146 symptoms. There were marked differences in the incidence of @entity146 symptoms among studies. This may be because @entity146 symptoms are readily overlooked in routine practice in the Department of Internal Medicine, and because @entity3027 treatment frequently causes transient @entity308 . It was speculated that @entity146 intervention was required in 10-19% of the @entity1 . We found that among @entity146 symptoms related to @entity3027 treatment, @entity308 with @entity146 and @entity148 was commonly observed. In many case reports, @entity1316 was noted as a precursory or residual symptom of @entity933 and @entity1833 /delusion. We present management guidelines for @entity146 symptoms in @entity3027 treatment, and propose that self-assessment scaling should be performed before and during treatment to detect @entity146 symptoms in the early stage, and that @entity1 with suspected symptoms should be promptly referred to the Department of Psychiatry. We introduce an open study of antidepressant treatment for @entity308 related to @entity3027 treatment, and recommend aggressive administration of antidepressants. @entity3027 treatment should be discontinued in @entity1 with: moderate or severe suicidal ideation or suicide attempt, @entity308 that does not respond to antidepressant treatment, @entity162 state, @entity1833 /delusion, or @entity933 .
